Basic↦Drug or Device↦Therapeutic Products↦Generic Products
What is it? Why is it important?
A generic medicinal product is an additional brand of an already existing Medicinal Product (i.e. the original preparation).
An “original preparation” is the first Medical Product with a specific active substance (i.e. the chemistry that makes the drug work) that has been authorised by regulatory authorities (i.e. including all authorised dosage forms).
A generic medicinal product:
- Is essentially the same as an original preparation as it contains the same active ingredient (e.g. bioequivalent)
- Is interchangeable with the original preparation due to its identical active substances, administration route (e.g. tablet, injection, infusion) and dosage form (e.g. x mg / day, x ml / per body weight)
- Complies with the same safety and quality criteria as the original preparation.
The acceptance criteria of the generic drug must be no less than 80% or no more than 125% of the original product, and must be authorised by regulatory authorities (e.g. Swissmedic)
More
Reference preparation:
- Is a biological Medicinal Product
- Is used in the authorisation documentation for a biosimilar product as a reference for the comparability of its pharmaceutical quality, efficacy and safety
Biosimilar product:
- Biological medicinal product
- Sufficiently similar to a reference preparation authorised by the Swissmedic
- Refers to its documentation
What do I need to do?
Note: The “Drug & Device” section addresses Medicinal Products and Medical Devices. “In Vitro Medical Devices” are not discussed In the Easy-GCS.
Where can I get help?
Your local Research Support Centre↧ can assist you with experienced staff regarding this topic
Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch
Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch
Bern, Department of Clinical Research (DCR), dcr.unibe.ch
Geneva, Clinical Research Center (CRC), crc.hug.ch
Lausanne, Clinical Research Center (CRC), chuv.ch
St. Gallen, Clinical Trials Unit (CTU), h-och.ch
Zürich, Clinical Trials Center (CTC), usz.ch
Swiss Law
TPA – see in particular article
- Art. 4 Definition generic medicinal products